S(+)-ketamine attenuates myogenic motor-evoked potentials at or distal to the spinal α-motoneuron

Anesthesia and Analgesia

Volumn 96, Issue 1, 2003, Pages 238-244

  Scheufler, Kai Michael ^a,c   Thees, Christof ^b   Nadstawek, Joachim ^b   Zentner, Josef ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM BESILATE; CISATRACURIUM; KETAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTRODE; ELECTROSTIMULATION; EVOKED MUSCLE RESPONSE; FORELIMB; HINDLIMB; MALE; MOTOR CORTEX; MULTIVARIATE ANALYSIS; MUSCLE ACTION POTENTIAL; NEUROMUSCULAR BLOCKING; NONHUMAN; PRIORITY JOURNAL; RABBIT; REGRESSION ANALYSIS; SPINAL CORD MOTONEURON; THORACIC SPINAL CORD;

ACTION POTENTIALS; ALGORITHMS; ANIMALS; ELECTRIC STIMULATION; EVOKED POTENTIALS, MOTOR; EXCITATORY AMINO ACID ANTAGONISTS; KETAMINE; MALE; MOTOR CORTEX; MOTOR NEURONS; MUSCLE, SKELETAL; RABBITS; REGRESSION ANALYSIS; SPINAL CORD; STEREOTAXIC TECHNIQUES;

EID: 0037219225     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200301000-00048     Document Type: Article

References (25)

1. Kawaguchi M, Inoue S, Kakimoto M, et al. The effect of sevoflurane on myogenic motor-evoked potentials induced by single and paired transcranial electrical stimulation of the motor cortex during nitrous oxide/ketamine/fentanyl anesthesia. J Neurosurg Anesthesiol 1998;10:131-6.
2. Scheufler KM, Zentner J. Total intravenous anesthesia for intraoperative monitoring of motor evoked potentials: An integral view combining clinical and experimental data. J Neurosurg 2002;96:571-9.
3. Sihle-Wissel M, Scholz M, Cunitz G. Transcranial magnetic-evoked potentials under total intravenous anaesthesia and nitrous oxide. Br J Anaesth 2000;85:465-7.
4. Sakamoto T, Kawaguchi M, Inoue S, Furuya H. Suppressive effect of nitrous oxide on motor evoked potentials can be reversed by train stimulation in rabbits under ketamine/fentanyl anaesthesia, but not with additional propofol. Br J Anaesth 2001;86:395-402.
5. Zentner J, Thees C, Pechstein U, et al. Influence of nitrous oxide on motor-evoked potentials. Spine 1997;22:1002-6.
6. Rhoney DH, Parker D. Use of sedative and analgesic agents in neurotrauma patients: Effects on cerebral physiology. Neurol Res 2001;23:237-59.
7. Engelhard K, Werner C, Mollenberg O, Kochs E. S(+)-ketamine/propofol maintain dynamic cerebrovascular autoregulation in humans. Can J Anaesth 2001;48:1034-9.
8. Geisslinger G, Hering W, Thomann P, et al. Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth 1993;70:666-71.
9. Himmelseher S, Pfenninger E, Georgieff M. The effects of ketamine-isomers on neuronal injury and regeneration in rat hippocampal neurons. Anesth Analg 1996;83:505-12.
10. Reeker W, Werner C, Mollenberg O, et al. High-dose S(+)-ketamine improves neurological outcome following incomplete cerebral ischemia in rats. Can J Anaesth 2000;47:572-8.
11. Liu HT, Hollmann MW, Liu WH, et al. Modulation of NMDA receptor function by ketamine and magnesium: Part I. Anesth Analg 2001;92:1173-81.
12. Henthorn TK, Krejcie TC, Niemann CU, et al. Ketamine distribution described by a recirculatory pharmacokinetic model is not stereoselective. Anesthesiology 1999;91:1733-43.
13. Yamakura T, Sakimura K, Shimoji K. The stereoselective effects of ketamine isomers on heteromeric N-methyl-D-aspartate receptor channels. Anesth Analg 2000;91:225-9.
14. Zeilhofer HU, Swandulla D, Geisslinger G, Brune K. Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol 1992;213:155-8.
15. Oye I, Paulsen O, Maurset A. Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 1992;260:1209-13.
16. Hirota K, Okawa H, Appadu BL, et al. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells. Anesthesiology 1999;90:174-82.
17. Finck AD, Ngai SH. Opiate receptor mediation of ketamine analgesia. Anesthesiology 1982;56:291-7.
18. Frenkel C, Urban BW. Molecular actions of racemic ketamine on human CNS sodium channels. Br J Anaesth 1992;69:292-7.
19. Brau ME, Sander F, Vogel W, Hempelmann G. Blocking mechanisms of ketamine and its enantiomers in enzymatically demyelinated peripheral nerve as revealed by single-channel experiments. Anesthesiology 1997;86:394-404.
20. Tassonyi E, Charpantier E, Muller D, et al. The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain Res Bull 2002;57:133-50.
21. Suzuki R, Matthews EA, Dickenson AH. Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy. Pain 2001;91:101-9.
22. Kienbaum P, Heuter T, Pavlakovic G, et al. S(+)-ketamine increases muscle sympathetic activity and maintains the neural response to hypotensive challenges in humans. Anesthesiology 2001;94:252-8.
23. Ghaly RF, Ham JH, Lee JJ. High-dose ketamine hydrochloride maintains somatosensory and magnetic motor evoked potentials in primates. Neurol Res 2001;23:881-6.
24. Deletis V, Rodi Z, Amassian VE. Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans. II. Relationship between epidurally and muscle recorded MEPs in man. Clin Neurophysiol 2001;112:445-52.
25. Koyuncuoglu H, Kara I, Gunel MA, et al. N-methyl-D-aspartate antagonists, glutamate release inhibitors, 4-aminopyridine at neuromuscular transmission. Pharmacol Res 1998;37:485-91.